Clinical Drug Experience Knowledgebase

Alzheimer Disease (Phase 2)

Amyotrophic Lateral Sclerosis (Phase 2)

Anemia, Iron-Deficiency (Phase 4)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Cognitive Dysfunction (Phase 2)

Deafness (Phase 2)

Dementia (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 1 (Phase 2)

Endometrial Neoplasms (Phase 2)

Familial Primary Pulmonary Hypertension (Phase 3)

Hearing Loss (Phase 2)

Hearing Loss, Sensorineural (Phase 2)

Heart Failure (Phase 4)

Hypertension (Phase 3)

Infarction (Phase 4)

Lewy Body Disease (Phase 2)

Lymphoma, Non-Hodgkin (Phase 1)

Motor Neuron Disease (Phase 2)

Multiple Sclerosis (Phase 2)

Multiple Sclerosis, Relapsing-Remitting (Phase 2)

Muscular Dystrophies (Phase 1)

Muscular Dystrophy, Duchenne (Phase 1)

Myocardial Infarction (Phase 4)

Opioid-Related Disorders (Phase 4)

Pain, Postoperative (Phase 3)

Parkinson Disease (Phase 2)

Parkinsonian Disorders (Phase 1)

Psoriasis (Phase 1)

Psychotic Disorders (Phase 2)

Radiculopathy (Phase 3)

Schizophrenia (Phase 2)

Schnitzler Syndrome (Phase 2)

Sclerosis (Phase 2)

Seizures (Phase 1)

Syndrome (Phase 2)

Toothache (Phase 3)

Urticaria (Phase 2)

Vasculitis (Phase 2)